| Ambetter Health Texas Superior Marketplace Clinical | Cosibelimab-ipdl | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Cosyntropin | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Crizanlizumab-tmca | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Factor VIII/von Willebrand Factor Complex; von Willebrand Factor | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Factor XIII A-Subunit, Recombinant | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Factor XIII, Human | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Fam-Trastuzumab Deruxtecan-nxki | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Faricimab-svoa | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Fecal Microbiota, Live-jslm | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Ferric Carboxymaltose | 2026-02-01 |